Sign in
4

Changes in Ownership

Altimmune, Inc. Filed Acc 0000899243-19-023318

Options or other derivatives

  • Chief Medical Officer acquired 107,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Harris Matthew Scott Chief Medical Officer 2019-09-09 Grant or award · Stock Options (option to buy) +107,000 107,000 D
Loading xslF345X03/doc4.xml…